Inventor · disambiguated record
Rohan Eric John Beckwith
Also filed as: BECKWITH ROHAN · BECKWITH ROHAN ERIC JOHN
14 granted patents·15 pending applications·79 citations·filing 2006–2025
91Inventor score
Top patents by PatentIndex Score
29 records- 0196US10414755B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2018·Granted Sep 17, 2019·18 cites·25 claims
- 0295US11053218B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2020·Granted Jul 6, 2021·4 cites·21 claims
- 0395US10647701B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2019·Granted May 12, 2020·13 cites·16 claims
- 0495US10640489B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2019·Granted May 5, 2020·13 cites·64 claims
- 0592US9504747B2Lipids and lipid compositions for the delivery of active agentsBARYZA JEREMY LEE·Filed 2014·Granted Nov 29, 2016·10 cites·21 claims
- 0689US11185537B23-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2019·Granted Nov 30, 2021·6 cites·17 claims
- 0786US11833142B23-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2021·Granted Dec 5, 2023·1 cites·5 claims
- 0885US10125092B2Lipids and lipid compositions for the delivery of active agentsBECKWITH ROHAN ERIC JOHN·Filed 2015·Granted Nov 13, 2018·5 cites·23 claims
- 0985US10124065B2Lipids and lipid compositions for the delivery of active agentsNOVARTIS AG·Filed 2014·Granted Nov 13, 2018·8 cites·21 claims
- 1075US11999802B2Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2018·Granted Jun 4, 2024·1 cites·33 claims
- 1173US2021309638A13-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1271US2024384007A1Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1368US10729775B2Lipids and lipid compositions for the delivery of active agentsNOVARTIS AG·Filed 2018·Granted Aug 4, 2020·0 cites·21 claims
- 1465US10844002B2Lipids and lipid compositions for the delivery of active agentsNOVARTIS AG·Filed 2018·Granted Nov 24, 2020·0 cites·24 claims
- 1564US2022117945A1Isoxazole carboxamide compounds and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1661US2025289802A13-(1-oxo-5-(piperidin-4-yl)isoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1759US2017196979A1Lipids and lipid compositions for the delivery of active agentsBARYZA JEREMY LEE·Filed 2016·Application pending·0 cites
- 1859US2018271837A1Isoxazole carboxamide compounds and uses thereofNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1956US2025276964A1Benzisoxazole Derivatives and Uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2055US2023271940A1Heteroaryl substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2155US2022144807A13-(1-oxo-5-(piperidin-4-yl)isoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2254US2021355115A1Isoxazole carboxamide compounds and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2350US10792361B2Lipids and lipid compositions for the delivery of active agentsNOVARTIS AG·Filed 2018·Granted Oct 6, 2020·0 cites·1 claims
- 2449US12479817B2Substituted 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2020·Granted Nov 25, 2025·0 cites·25 claims
- 2549US2022363671A1Glue degraders and methods of use thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2647US2010093776A1Organic Compounds and Their UsesNOVARTIS AG·Filed 2007·Application pending·0 cites
- 2741US2010048597A1Organic Compounds and Their UsesNOVARTIS AG·Filed 2007·Application pending·0 cites
- 2840US2008306067A1Modulators of Chemokine Receptor ActivityWEIGAND KLAUS·Filed 2006·Application pending·0 cites
- 2940US2008207718A1Use of Fused Imidazole Derivatives to Mediate Ccr3 Related ConditionsBECKWITH ROHAN·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →